- Retraction Note
- Open access
- Published:
Retraction Note: Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA
Journal of Experimental & Clinical Cancer Research volume 42, Article number: 82 (2023)
The Original Article was published on 27 July 2018
Retraction Note:  J Exp Clin Cancer Res  37, 171 (2018)
The Editor-in-Chief has retracted this article. Concerns were raised regarding a number of figures, including but not limited to:
-
Figure 1a appears to be identical to Figure 2B in an article by different authors describing different studies that was simultaneously under consideration at a different journal [1] but flipped horizontally.
-
Figure 2f appears to overlap with Figure 2F in a previously published article [3] and Figure 4C in an article by different authors that was simultaneously under consideration [4].
-
Figure 3e appears to be identical to Figure 2c in a previously published article [2].
-
Figure 7c appears to be identical to Figure 5B in an article by different authors describing different studies that was simultaneously under consideration at a different journal [1].
-
Figure 8a appears to be identical to Figure 6A in an article by different authors describing different studies that was simultaneously under consideration at a different journal [1].
The Editor-in-Chief therefore no longer have confidence in the results and conclusions of this article.
The authors have not responded to correspondence regarding this retraction.
References
Li X, Zhang Z, Jiang H, Li Q, Wang R, Pan H, Niu Y, Liu F, Gu H, Fan X, Gao J. Circular RNA circPVT1 promotes proliferation and Invasion through sponging miR-125b and activating E2F2 signaling in Non-Small Cell Lung Cancer. Cell Physiol Biochem. 2018;51:2324–40. https://doi.org/10.1159/000495876.
Liu H, Zhou G, Fu X, Cui H, Pu G, Xiao Y, Sun W, Dong X, Zhang L, Cao S, Li G, Wu X, Yang X et al. Long noncoding RNA TUG1 is a diagnostic factor in lung adenocarcinoma and suppresses apoptosis via epigenetic silencing of BAX. Oncotarget. 2017; 8: 101899–101910. Retrieved from https://www.oncotarget.com/article/22058/text/
Zhang W, Cai X, Yu J, Lu X, Qian Q, Qian W. Exosome-mediated transfer of lncRNA RP11-838N2.4 promotes erlotinib resistance in non-small cell lung cancer retraction in /10.3892/ijo.2022.5458. Int J Oncol. 2018;53:527–38. https://doi.org/10.3892/ijo.2018.4412.
Dong H, Wang W, Mo S, et al. RETRACTED ARTICLE: SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88. J Exp Clin Cancer Res. 2018;37:202. https://doi.org/10.1186/s13046-018-0875-3.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1186/s13046-018-0845-9.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Kang, M., Ren, M., Li, Y. et al. Retraction Note: Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA. J Exp Clin Cancer Res 42, 82 (2023). https://doi.org/10.1186/s13046-023-02648-7
Published:
DOI: https://doi.org/10.1186/s13046-023-02648-7